aXichem AB (STO:AXIC.A)

Market Cap	171.43M
Revenue (ttm)	11.15M
Net Income (ttm)	-18.38M
Shares Out	59.11M
EPS (ttm)	-0.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,132
Average Volume	81,630
Open	2.860
Previous Close	2.900
Day's Range	2.730 - 2.930
52-Week Range	0.968 - 3.390
Beta	-0.26
RSI	60.99
Earnings Date	Aug 28, 2025

About aXichem AB

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is b...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1999
• Employees: 7
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: AXIC.A

Financial Performance

In 2024, aXichem AB's revenue was 8.57 million, an increase of 373.74% compared to the previous year's 1.81 million. Losses were -17.81 million, -14.41% less than in 2023.